Absci Corporation (ABSI) vs Intellia Therapeutics, Inc. (NTLA)
A side-by-side comparison of Absci Corporation and Intellia Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABSI
Absci Corporation
$10.85HealthcareDelayed quote: Oct 6, 2026, 11:50 AM EDT
NTLA
Intellia Therapeutics, Inc.
$12.43HealthcareDelayed quote: Oct 6, 2026, 11:50 AM EDT
Total return — ABSI vs NTLA
growth of $100 · dividends reinvested · last 5yABSI -46.6% (-11.8%/yr)NTLA -91.4% (-38.7%/yr)ABSI compounded faster over this window
Log scale — wide-divergence pair
ABSI NTLA
ABSI vs NTLA: by the numbers
- •ABSI is the larger company ($1.84B vs $1.74B market cap).
- •Both run net losses; NTLA's is the smaller (-672.16% vs -7756.37% net margin).
- •NTLA grew revenue faster over the past five years (7.31% vs -22.08% CAGR).
Metrics side by side
Valuation
| Metric | ABSI | NTLA |
|---|---|---|
| P/S ratio | 1176.90 | 29.17 |
| P/B ratio | 7.46 | 2.39 |
Profitability
| Metric | ABSI | NTLA |
|---|---|---|
| Gross margin | -319.36% | 76.47% |
| Operating margin | -4454.21% | -651.67% |
| Net margin | -7756.37% | -672.16% |
| ROE | -49.19% | -54.96% |
| ROIC | -52.66% | -54.45% |
Growth (annualized)
| Metric | ABSI | NTLA |
|---|---|---|
| Revenue CAGR (5Y) | -22.08% | 7.31% |
| Total return CAGR (5Y) | 0.89% | -37.13% |
Frequently asked
- Which has grown faster, ABSI or NTLA?
- Over the past five years, NTLA grew revenue faster — ABSI at a -22.08% CAGR versus NTLA at 7.31%.
- How have ABSI and NTLA total returns compared?
- Over the past 5 years, ABSI delivered 0.89% and NTLA delivered -37.13% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.